StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Raised to $73 at BMO Capital on 3Q Preview; 'In-Line to Incrementally Positive Quarter'
October 10, 2017 9:42 AM
BMO Capital raised its price target on Eli Lilly (NYSE: LLY) to $73.00 (from $71.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Wal-Mart rally pushes Dow to all-time high
October 10, 2017 7:32 AM
Eli Lilly & Co. (LLY) Announces Topline Results from Phase 3 JUNIPER Trial Evaluating Verzenio (Abemaciclib)
October 10, 2017 6:46 AM
Credit Suisse Downgrades Eli Lilly (LLY) to Neutral
October 10, 2017 4:59 AM
Eli Lilly & Co. (LLY) Reports Interim Results for MONARCH 3 Study Highlighting Benefit of Verzenio (Abemaciclib) Plus NSAI in Advanced Breast Cancer
October 6, 2017 1:02 PM